6168 Results

People

  1. Perales
    Perales
  2. Drilon
    Drilon
  3. Usmani
    Usmani
  4. Giralt
    Giralt
  5. Ladanyi
    Ladanyi
  6. Salles
    Salles
  7. Abu-Rustum
    Abu-Rustum
  8. Gonen
    Gonen
  9. Dee
    Dee
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)
  7. Graduate Medical Education (957)
  8. Survivorship Research (906)
  9. Department of Pathology and Laboratory Medicine (841)
  10. Center for Hematologic Malignancies (830)
  1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of alpelisib-associated hyperglycemia in metastatic breast cancer
    Meeting Abstract

    Shen, S.; Chen, Y.; Carpio, A.; Chang, C.; Iyengar, N. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM)
    Meeting Abstract

    Skakodub, A.; Tringale, K. R.; Walch, H. S.; Vasudevan, H.; Eichholz, J.; Kelly, D. W.; Moss, N. S.; Yu, K. K. H.; Li, B. T.; Mueller, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of trametinib in combination with paclitaxel in the treatment of anaplastic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Michel, L. S.; Kriplani, A.; Dunn, L.; Haque, S.; Bang, D.; Stein, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19)
    Meeting Abstract

    Shah, D. P.; Shah, P.; Warner, J. L.; Batist, G.; Friese, C. R.; Griffiths, E. A.; Hwang, C.; Vieira, K.; McKay, R. R.; Mesa, R. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Healthcare resource utilization (HCRU) and costs for patients (pts) with metastatic renal cell carcinoma (mRCC) receiving first-line (LOT1) pembrolizumab plus axitinib (P+A) or ipilimumab plus nivolumab (I+N)
    Meeting Abstract

    Shah, N. J.; Shinde, R.; Moore, K.; Sainski-Nguyen, A.; Le, L.; Cao, F.; Song, R.; Singhal, P.; Motzer, R. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell (ccRCC) carcinoma who have received front-line treatment (NCT04300140)
    Meeting Abstract

    Shah, N. J.; Beckermann, K.; Vogelzang, N. J.; Mao, S. S.; Ornstein, M. C.; Hammers, H. J.; Gao, X.; McDermott, D. F.; Haas, N. B.; Yan, H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Development of Memorial Sloan Kettering (MSK) surgery stress score for older adults with cancer
    Meeting Abstract

    Shahrokni, A.; Tin, A. L.; Downey, R. J.; Bochner, B. H.; Nash, G. M.; Kim, S. J.; Afonso, A.; Korc-Grodzicki, B.; Vickers, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cancer doesn't know what day of the week it is: Temporal trends in day of death, 2000-2017
    Meeting Abstract

    Shah, K.; Tao, A.; Chino, J. P.; Chino, F.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer
    Meeting Abstract

    Shen, S.; Ma, W.; Zhou, Q.; Iasonos, A.; Zhang, Y.; Ross, D. S.; Makker, V.; Chui, M. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save